PMID- 32523843
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 12
IP  - 5
DP  - 2020 May 6
TI  - The Effect of Enhanced External Counterpulsation (EECP) on Quality of life in 
      Patient with Coronary Artery Disease not Amenable to PCI or CABG.
PG  - e7987
LID - 10.7759/cureus.7987 [doi]
LID - e7987
AB  - Enhanced External Counterpulsation (EECP) is a non-invasive FDA approved therapy 
      for patients with refractory angina pectoris. The EECP mechanism of action is 
      similar to that of an intra-aortic balloon pump (IABP) by administering a 
      vigorous pressure pulse via external blood pressure cuffs during the diastole. 
      The benefit of EECP includes improvement in angina severity, angina stability, 
      maximal walking capacity and generalized improvement in overall health. Seatle 
      Angina Questionnaire (SAQ) is a valid, reliable and sensitive measure of 
      health-related quality of life. It is also a sensitive and reproducible 
      evaluation tool to measure the response to an intervention. We did a pre-test 
      post-test designed prospective study to evaluate the effect of EECP on the 
      quality of life in patients with CAD. There was a significant difference between 
      SAQ-7 health-related quality of life between the pre-EECP and post-EECP groups (P 
      value= <0.01). Moreover, a positive correlation was reported between the New York 
      Heart Association (NYHA) Functional Classification before treatment and post-EECP 
      SAQ-7 health-related quality of life (P value=0.015).
CI  - Copyright (c) 2020, Jan et al.
FAU - Jan, Rafiullah
AU  - Jan R
AD  - Cardiology, Hayatabad Medical Complex, Peshawar, PAK.
FAU - Khan, Asghar
AU  - Khan A
AD  - Cardiology, Hayatabad Medical Complex, Peshawar, PAK.
FAU - Zahid, Salman
AU  - Zahid S
AD  - Internal Medicine, Khyber Teaching Hospital, Peshawar, PAK.
FAU - Sami, Abdul
AU  - Sami A
AD  - Cardiology, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
FAU - Owais, Syed M
AU  - Owais SM
AD  - Internal Medicine, Hayatabad Medical Complex, Peshawar, PAK.
FAU - Khan, Fahad
AU  - Khan F
AD  - Internal Medicine, Khyber Teaching Hospital, Peshawar, PAK.
FAU - Asjad, Sayyed Jalawan
AU  - Asjad SJ
AD  - Internal Medicine, Hayatabad Medical Complex, Peshawar, PAK.
FAU - Jan, Muhammad Hassan
AU  - Jan MH
AD  - Internal Medicine, Hayatabad Medical Complex, Peshawar, PAK.
FAU - Awan, Zahid A
AU  - Awan ZA
AD  - Cardiology, Hayatabad Medical Complex, Peshawar, PAK.
LA  - eng
PT  - Journal Article
DEP - 20200506
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC7273423
OTO - NOTNLM
OT  - coronary artery disease
OT  - counterpulsation
OT  - heart failure
OT  - quality of life
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/06/12 06:00
MHDA- 2020/06/12 06:01
PMCR- 2020/05/06
CRDT- 2020/06/12 06:00
PHST- 2020/06/12 06:00 [entrez]
PHST- 2020/06/12 06:00 [pubmed]
PHST- 2020/06/12 06:01 [medline]
PHST- 2020/05/06 00:00 [pmc-release]
AID - 10.7759/cureus.7987 [doi]
PST - epublish
SO  - Cureus. 2020 May 6;12(5):e7987. doi: 10.7759/cureus.7987.